In the HPV58 tumor-bearing mice, the CD4+/CD8+ ratio of the vaccine group were significantly decreased, while the CD8+ lymphocyte ratio was significantly increased compared with those of the PBS blank control group and the AD-NC group (P < 0.05). The gene discussed is CD8A; the disease is neoplasm.